Summary & Overview

CPT 52240: Cystoscopy with Destruction of Bladder/Urethral Lesions >5.0 cm

CPT code 52240 designates a diagnostic cystoscopy combined with destructive treatment (fulguration or ablation) of bladder or urethral lesions larger than 5.0 cm using electrosurgery, cryotherapy, or laser. This code captures a bundled endoscopic inspection plus active lesion destruction and is relevant nationally because it affects billing for urologic tumor and lesion management in outpatient surgical settings. Proper use of the code influences reporting, reimbursement, and quality measurement for procedures addressing large bladder lesions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how CPT code 52240 is defined, typical clinical scenarios for its use, and the usual sites of service where it is performed. Readers will find a concise clinical context describing the procedure, benchmarking considerations for common payers, and notes on coding boundaries and related service definitions. Where payer‑specific policies or coverage rules apply, readers will receive an overview of the common commercial and federal payer perspectives. Data not available in the input are noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare52240CPTurologycystoscopyfulgurationablationoutpatient-surgeryendoscopy

Billing Code Overview

CPT code 52240 describes cystoscopic inspection of the urethra, prostatic urethra (in men), bladder interior, and ureteric orifices with destruction (fulguration) of lesions larger than 5.0 cm using high‑intensity electric current, cryosurgery (intense cold), or laser (intense heat).

Service type: Endoscopic cystoscopic procedure with lesion destruction (fulguration/ablation)
Typical site of service: Outpatient ambulatory surgery center or hospital outpatient department; may also be performed in an operating room when clinically indicated

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 68-year-old male with a history of gross hematuria and recurrent non–muscle-invasive bladder tumors presents for transurethral fulguration of bladder lesions. After preoperative evaluation and informed consent, the patient is brought to the ambulatory surgical suite. Under general or regional anesthesia, a cystoscope is introduced through the urethra to inspect the urethra, prostatic urethra, bladder interior, and ureteric orifices. Visualized papillary tumors larger than 5.0 cm are fulgurated using high‑intensity electrical current or alternative energy modalities (laser or cryotherapy) to ablate visible disease. Hemostasis is confirmed, and a urinary catheter may be placed for short-term drainage. The typical workflow includes preop assessment, anesthesia, cystoscopic inspection, lesion destruction, specimen handling if biopsies or TUR components are performed, recovery, and follow-up surveillance cystoscopy scheduling.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work, time, and technical effort substantially exceed usual for cystoscopic fulguration (document increased complexity).
`23`	Unusual anesthesia	Use when procedure is performed under general anesthesia due to patient condition when local/regional expected.
`50`	Bilateral procedure	Not typically applicable; listed for completeness if bilateral anatomic sites are applicable.
`51`	Multiple procedures	Use when additional unrelated procedures are performed during the same session (report primary CPT first).
`52`	Reduced services	Use when the fulguration is partially reduced or incomplete (document reason).
`53`	Discontinued procedure	Use if procedure is started but aborted due to complication or patient instability.
`58`	Staged or related procedure or service by same physician during postoperative period	Use when fulguration is planned as a staged procedure following an initial diagnostic cystoscopy.
`59`	Distinct procedural service	Use when fulguration is a distinct procedure separate from other cystoscopic interventions performed same day (document distinctness).
`62`	Two surgeons	Use when two surgeons with different NPI actively participate for a separate, substantive reason.
`76`	Repeat procedure by same physician	Use when the fulguration is repeated later the same day (if applicable).
`TC`	Technical component	Use when billing only the facility/technical component (physician bills professional component separately).
`26`	Professional component	Use when billing only the physician/professional portion (facility bills TC).

Taxonomy Code	Specialty	Notes
208800000X	Urology	Primary specialty performing cystoscopic fulguration of bladder lesions.
208D00000X	Urologic Oncology	Subspecialty managing complex or recurrent bladder tumors.
207Q00000X	General Surgery	Occasionally performs endoscopic bladder procedures in certain settings.
364S00000X	Anesthesiology	Provides anesthesia services during the procedure.
261QM0800X	Surgical Oncology	May participate for multidisciplinary bladder cancer management.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C67.9`	Malignant neoplasm of bladder, unspecified	Primary diagnosis for fulguration of papillary bladder tumors as part of bladder cancer management.
`D41.4`	Neoplasm of uncertain behavior of bladder	Used when a bladder lesion is of uncertain malignant potential and fulguration is performed.
`R31.9`	Hematuria, unspecified	Symptom prompting diagnostic cystoscopy and possible fulguration of bleeding lesions.
`N32.0`	Bladder neck obstruction	May be assessed during cystoscopy; incidental lesions can be fulgurated if present.
`N39.0`	Urinary tract infection, site not specified	Infection may coexist and influence perioperative management; cystoscopy may identify source.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`52000`	Cystourethroscopy, diagnostic, with or without collection of specimen(s) by brushing or washing	Performed for initial diagnostic inspection prior to fulguration when no tissue resection is required.
`52235`	Cystourethroscopy, with fulguration (including cryosurgery or laser) of small lesions 1.0 cm or less	Used for fulguration when lesion size is <= 1.0 cm; smaller lesion code compared to `52240`.
`52234`	Cystourethroscopy, with fulguration of lesions 1.1 to 3.0 cm	Used for intermediate-size lesions; selection depends on measured lesion size.
`52241`	Cystourethroscopy, with fulguration of lesions 3.1 to 5.0 cm	Used when lesion sizes fall in the 3.1–5.0 cm range; `52240` applies to lesions larger than 5.0 cm.
`52204`	Cystourethroscopy, with biopsy(s) of bladder and/or urethral lesion(s)	Performed when biopsy specimens are taken in addition to or instead of fulguration.
`51701`	Implantation of temporary bladder catheter (e.g., intermittent)	May be used when short-term catheter placement is required post‑procedure.